Talk:Cyproterone acetate

This is the talk page for discussing improvements to the Cyproterone acetate article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Cyproterone acetate.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Chemicals Mid‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Women's Health High‑importance

	This article is within the scope of WikiProject Women's Health, a collaborative effort to improve the coverage of Women's Health on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Women's HealthWikipedia:WikiProject Women's HealthTemplate:WikiProject Women's Healthwomen's health articles
High	This article has been rated as High-importance on the importance scale.

Archives

Archive 1

please do not use words like "trangender" or "transsexual". Because they offend the gender identity of people. Thanks :) — Preceding unsigned comment added by Lidia9000 (talk • contribs) 10:52, 22 October 2018 (UTC)[reply]

Uhh, no. "Transgender" and "transsexual" are not offensive words. — Preceding unsigned comment added by 24.11.72.84 (talk) 19:23, 14 August 2019 (UTC)[reply]

CPA vs Spiro

In the Transgender Hormone Therapy section it's mentioned that CPA has "an advantage over spironolactone as an antiandrogen in transgender people, as the combination of estrogen and CPA consistently suppresses testosterone levels into the normal female range whereas estrogen with spironolactone does not.". Unless I've got this wrong, this is technically both a true and false statement: CPA does reduce androgen production far more than Spiro, however it is not an advantage because their respective modes of operation are completely different (in the context of transgender hormone therapy): Spiro works to block the androgen receptors throughout the body, whereas CPA stops the production of the androgens to begin with. Therefore naturally you would see differing androgen levels in people taking CPA vs Spiro, but that's not helpful; you need a different metric to compare the feminizing capability of these medications. Aspenpaw (talk) 06:35, 19 November 2024 (UTC)[reply]